Hims vs Lemonaid Health: GLP-1 Program Comparison 2026

Platform Backgrounds

Hims

Hims launched in 2017 and quickly became one of the most recognizable names in direct-to-consumer telehealth. The company went public in 2021 and has continued expanding its services. Their weight loss program uses compounded semaglutide delivered through a vertically integrated model: consultation, prescription, and fulfillment all happen within the Hims ecosystem.

Lemonaid Health

Lemonaid Health was founded as an affordable, accessible telehealth service. It was acquired by 23andMe in 2021, adding a genetics dimension to the company's capabilities. Lemonaid offers consultations for many conditions, including weight management. Their GLP-1 program connects patients with providers who can prescribe compounded or brand-name medications, depending on availability and patient eligibility.

Feature Comparison

Hims: Pros and Cons

Pros

• All-inclusive monthly price covers consultation, medication, and shipping
• Highly polished app with smooth prescription management
• Large provider network ensures quick matching
• Strong brand recognition and trust
• Consistent supply through partner compounding pharmacies

Cons

• Primarily limited to compounded semaglutide
• No genetic or biometric integration
• Consultation model is mostly asynchronous
• No lifestyle coaching or nutritional support

Lemonaid Health: Pros and Cons

Pros

• May offer both compounded and brand-name GLP-1 medications
• Potential for genetic insights through 23andMe integration
• Affordable consultation fees
• Broad range of telehealth services for other health needs
• Option to fill prescriptions at retail pharmacies

Cons

• Medication cost may be separate from the consultation fee, making total cost less transparent
• Less polished weight-loss-specific experience compared to Hims
• 23andMe's financial challenges have created uncertainty about the platform's future
• GLP-1 program may not be as mature as dedicated weight loss platforms
• Availability of specific medications can be inconsistent

The Genetics Angle

Lemonaid's connection to 23andMe opens an interesting possibility: using genetic data to inform weight loss treatment. Research has identified genetic variants that influence metabolism, appetite regulation, and response to specific medications. In theory, genetic insights could help providers choose the most effective medication and dosing strategy for each patient. For a complete cost breakdown, see our compare GLP-1 providers.

In practice, this integration is still evolving. Not all Lemonaid providers use genetic data in their prescribing decisions, and the clinical evidence for pharmacogenomic-guided weight loss treatment is still developing. It's a promising direction but not yet a proven advantage.

Hims doesn't offer any genetic testing or integration. Their approach is purely clinical: assess symptoms, prescribe medication, and monitor progress through standard provider-patient communication.

Pharmacy and Fulfillment

Hims controls the pharmacy experience through its partner compounding pharmacies. Medication is shipped directly to your home on a predictable schedule. This vertical integration means fewer surprises and a smoother refill process.

Lemonaid Health may offer more flexibility. Depending on the medication prescribed, you might receive compounded medication shipped to your home or a prescription sent to a retail pharmacy for pickup. This flexibility is useful if you prefer a local pharmacy or if your insurance covers brand-name GLP-1 medications at a specific retailer. The downside is that the experience can be less predictable.

Pricing Structure

Hims keeps pricing simple. You pay a monthly subscription that covers everything. No separate consultation fees, no surprise pharmacy charges. Contact provider for current pricing

Lemonaid Health may charge a consultation fee and separate medication cost. If you're getting compounded medication shipped through Lemonaid's pharmacy partner, the total may be comparable to Hims. If you're filling a brand-name prescription at a retail pharmacy, the medication cost depends on your insurance and the pharmacy's pricing. Contact provider for current pricing This model can be cheaper or more expensive than Hims depending on your specific situation.

Who Should Choose Hims?

Hims is the better choice if you want a predictable, all-in-one experience. You know what you're paying, you know what medication you're getting, and the app handles everything smoothly. If you value simplicity and brand reliability above all else, Hims delivers.

Who Should Choose Lemonaid Health?

Lemonaid Health is worth considering if you want flexibility in medication choice, are interested in genetic-informed treatment, or prefer the option to fill prescriptions at a local pharmacy. If you already have a 23andMe profile and want to explore how genetic data could inform your weight loss approach, Lemonaid is uniquely positioned to offer that.

FormBlends: A Physician-First Alternative

FormBlends provides physician-supervised GLP-1 programs with peptide wellness therapy. We focus on personalized clinical care with providers who specialize in weight management and metabolic health. If you want deeper medical oversight than what Hims or Lemonaid typically provides, our team is ready to help. See our GLP-1 programs

What Hims and Lemonaid Health actually charge right now (September 2026 price index)

The prices quoted in the sections above were checked when this comparison was written. The table below is different: it is pulled from the FormBlends Compounded GLP-1 Price Index, which records the all-in cash price for a 28-day supply from each provider's public pricing page every week. These are the rows for Hims and Lemonaid Health as of September 3, 2026. Month one is the starting dose (2.5 mg tirzepatide or 0.25 mg semaglutide); month four is the first maintenance step (5 mg or 1 mg).

Lemonaid Health is not tracked in the index yet, so no observed price is shown; check the program's own pricing page and compare it on the same all-in, 28-day basis.

For context, the index median for compounded tirzepatide at month one was $299 across 14 providers on September 3, 2026, and $197 for compounded semaglutide. Brand Zepbound through LillyDirect was $299 to $449 and the Wegovy pen $199 for the first two fills, then $349. The full dataset, methodology and a CSV download are at the Compounded GLP-1 Price Index, where FormBlends is listed under the same rules as every other provider.

Frequently Asked Questions

Is Lemonaid Health still operating after 23andMe's financial issues?

As of early 2026, Lemonaid Health continues to operate. But 23andMe's financial challenges have raised questions about the platform's long-term stability. Check Lemonaid's website for the most current status.

Can I use 23andMe results to get a better GLP-1 prescription?

Genetic data can provide useful insights, but pharmacogenomic prescribing for weight loss is still an emerging field. Not all providers will adjust prescriptions based on genetic data alone.

Which platform ships medication faster?

Hims typically ships within a few business days of provider approval. Lemonaid's timeline depends on whether you use their partner pharmacy or a retail pharmacy. Direct-ship options are usually comparable to Hims.

Do I need to see a provider in person for either platform?

No. Both platforms are fully virtual. Consultations, prescribing, and follow-ups all happen online.

Can I switch between Hims and Lemonaid without issues?

Yes. Share your current medication and dosage information with your new provider. Most transitions are straightforward, and you shouldn't need to restart your dosing protocol.